Quince Therapeutics, Inc.
QNCX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $21 | $45 | $70 |
| Short-Term Investments | $35 | $54 | $46 | $37 |
| Receivables | $1 | $1 | $0 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $4 | $4 |
| Total Curr. Assets | $44 | $77 | $94 | $112 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $18 | $0 | $0 |
| Intangibles | $60 | $64 | $6 | $0 |
| Long-Term Investments | $0 | $0 | $4 | $20 |
| Tax Assets | $0 | $12 | -$4 | $0 |
| Other NC Assets | $10 | $8 | $4 | $0 |
| Total NC Assets | $70 | $103 | $10 | $22 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $114 | $180 | $104 | $133 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $1 | $5 |
| Short-Term Debt | $0 | $0 | $0 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $7 | $2 | $9 |
| Total Curr. Liab. | $7 | $10 | $3 | $14 |
| LT Debt | $15 | $14 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $5 | $18 | $0 | $0 |
| Other NC Liab. | $57 | $54 | $0 | $0 |
| Total NC Liab. | $77 | $86 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $1 |
| Total Liabilities | $84 | $95 | $3 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$376 | -$320 | -$288 | -$237 |
| AOCI | -$0 | $3 | -$0 | -$0 |
| Other Equity | $407 | $402 | $389 | $355 |
| Total Equity | $30 | $85 | $101 | $119 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $114 | $180 | $104 | $133 |
| Net Debt | $9 | -$7 | -$44 | -$69 |